brofaromine

Known as: 4-(5-methoxy-7-bromobenzofuranyl)-2-piperidine, Piperidine, 4-(7-bromo-5-methoxy-2-benzofuranyl)-, hydrochloride, brofaromin 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
The reversible inhibitors of monoamine oxidase type A (RIMAs) are a newer group of antidepressants that have had much less impact… (More)
Is this relevant?
1999
1999
The effects of trazodone on subjective and objective sleep parameters were compared to those of placebo in a double-blind design… (More)
Is this relevant?
1997
1997
The safety and efficacy of brofaromine, a reversible and selective monoamine oxidase inhibitor, were examined in a multicenter… (More)
Is this relevant?
Highly Cited
1996
Highly Cited
1996
Chronic exposure to mild unpredictable stress has previously been found to depress the consumption of palatable sweet solutions… (More)
Is this relevant?
1995
1995
Seventy-seven patients with a primary diagnosis of social phobia (DSM-III-R) were randomized to treatment with the reversible and… (More)
Is this relevant?
1994
1994
Depressed outpatients (n = 51) resistant to treatment with maprotiline were treated in a blind, randomized, single-centre study… (More)
Is this relevant?
1992
1992
There is circumstantial evidence that antidepressants, particularly monoamine oxidase inhibitors (MAOIs) and beta-blockers, may… (More)
Is this relevant?
1989
1989
Healthy ambulatory subjects were treated p.o. for 2 to 4 weeks with 6 different MAO inhibitors (MAOI). MAOI drugs were given to… (More)
Is this relevant?
1989
1989
The inhibition of the binding of [3H]cyanoimipramine in the rat brain in vivo, with and without pretreatment with proadifen (SK… (More)
Is this relevant?
Review
1989
Review
1989
During the last years the MAO-inhibitors reached a progressive importance in clinical practice. It was attempted to solve… (More)
Is this relevant?